BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Division of Infectious Diseases//NONSGML Events//EN
CALSCALE:GREGORIAN
X-ORIGINAL-URL:https://infectiousdiseases.wustl.edu/events/
X-WR-CALDESC:Division of Infectious Diseases - Events
BEGIN:VEVENT
UID:20220818T1758Z-1660845536.2252-EO-28714-1@172.23.128.19
STATUS:CONFIRMED
DTSTAMP:20260311T134736Z
CREATED:20220817T015045Z
LAST-MODIFIED:20220830T191822Z
DTSTART;TZID=America/Chicago:20220915T174500
DTEND;TZID=America/Chicago:20220915T190000
RDATE;TZID=America/Chicago:20220915T174500
SUMMARY: ID Society of St. Louis In-person Reception with Exhibitors
DESCRIPTION: We thank our Exhibitors for their support on September 15\, 20
 22\, 5:50 pm – 7:00 pm prior to our CME event: Optimizing HIV Outcomes in C
 hallenging Scenarios.   Jeff Sava Senior Account Specialist 314-369-8815 je
 ffrey.sava@abbvie.com abbvie.com Avycaz\, Dalavance\, Teflaro Denise Brys S
 enior Hospital Representative 314-494-8796 dbrys@cumberlandpharma.com cumbe
 rlandpharma.com Vibativ – Telavancin Update Suzie Wulf Hospital Representat
 ive […]
X-ALT-DESC;FMTTYPE=text/html: <p class="lead">We thank our Exhibitors for t
 heir support on September 15\, 2022\, 5:50 pm – 7:00 pm prior to our CME ev
 ent: Optimizing HIV Outcomes in Challenging Scenarios.</p><p> </p><div clas
 s="wp-block-columns"><div class="wp-block-column"><p><img class="alignnone 
 size-full wp-image-23041" src="https://infectiousdiseases.wustl.edu/app/upl
 oads/2021/10/Abbvie-250px-wide.png" alt="" width="250" height="44" /></p><u
 l class="washu-ppi-contact-list"><li class="washu-ppi-contact"><strong>Jeff
  Sava</strong><br />Senior Account Specialist</li><li class="washu-ppi-phon
 e">314-369-8815</li><li class="washu-ppi-email"><a href="mailto:jeffrey.sav
 a@abbvie.com">jeffrey.sava@abbvie.com</a></li><li class="washu-ppi-website"
 ><a href="https://www.abbvie.com/our-company.html" target="_blank" rel="noo
 pener noreferrer">abbvie.com</a></li></ul><p><em><strong>Avycaz\, Dalavance
 \, Teflaro</strong></em></p><hr /><p><img class="size-full wp-image-28849" 
 style="font-weight: bold\; font-size: 1.125rem\;" src="https://infectiousdi
 seases.wustl.edu/app/uploads/2022/08/cumberland_pharmaceuticals_logoCR.jpg"
  alt="" width="360" height="83" /></p><div class="mceTemp"></div><ul class=
 "washu-ppi-contact-list"><li class="washu-ppi-contact"><strong>Denise Brys<
 /strong><br />Senior Hospital Representative</li><li class="washu-ppi-phone
 ">314-494-8796</li><li class="washu-ppi-email"><a href="mailto:dbrys@cumber
 landpharma.com">dbrys@cumberlandpharma.com</a></li><li class="washu-ppi-web
 site"><a href="https://www.cumberlandpharma.com/" target="_blank" rel="noop
 ener noreferrer">cumberlandpharma.com</a></li></ul><p><em><strong>Vibativ –
  Telavancin Update</strong></em></p><hr /><p><img class="alignnone size-ful
 l wp-image-23032" src="https://infectiousdiseases.wustl.edu/app/uploads/202
 1/10/insmed-transp-photoshop-250-wide.png" alt="" width="248" height="107" 
 /></p><ul class="washu-ppi-contact-list"><li class="washu-ppi-contact"><str
 ong>Suzie Wulf</strong><br />Hospital Representative</li><li class="washu-p
 pi-phone">314-614-7379</li><li class="washu-ppi-email"><a href="mailto:susi
 e.wulf@insmed.com">susie.wulf@insmed.com</a></li><li class="washu-ppi-websi
 te"><a href="https://www.ntmfacts.com/" target="_blank" rel="noopener noref
 errer">ntmfacts.com</a></li></ul><p><em><strong>Arikayce</strong></em></p><
 hr /><p><img class="alignnone wp-image-23042" src="https://infectiousdiseas
 es.wustl.edu/app/uploads/2021/10/Shiongi_logo.png" alt="" width="287" heigh
 t="43" /></p><ul class="washu-ppi-contact-list"><li class="washu-ppi-contac
 t"><strong>Mark Somraty</strong><br />Key Account Manager</li><li class="wa
 shu-ppi-phone">618-444-4831</li><li class="washu-ppi-email"><a href="mailto
 :mark.somraty@Shionogi.com">mark.somraty@Shionogi.com</a></li><li class="wa
 shu-ppi-website"><a href="http://www.shionogi.com/">shionogi.com</a></li></
 ul><p><em><strong>cefiderocol (Fetroja)</strong></em></p></div></div><hr />
 <p><img class="alignnone size-full wp-image-18335" style="font-size: 1.125r
 em\;" src="https://infectiousdiseases.wustl.edu/app/uploads/2020/12/favpng_
 gilead-sciences-logo-sofosbuvir-nasdaq-gild-health-care_nFRsNCcT-e160683958
 3450.png" alt="" width="238" height="67" /></p><div class="wp-block-columns
 "><div class="wp-block-column"><ul class="washu-ppi-contact-list"><li class
 ="washu-ppi-contact"><strong>Michael Lever</strong><br />Executive Therapeu
 tic Specialist</li><li class="washu-ppi-phone">314-407-6222</li><li class="
 washu-ppi-email">Michael.Lever@gilead.com</li><li class="washu-ppi-website"
 ><a href="https://www.gilead.com/">gilead.com</a></li></ul><hr /><p><img cl
 ass="alignnone size-full wp-image-23044" src="https://infectiousdiseases.wu
 stl.edu/app/uploads/2021/10/astellas-250px-wide.png" alt="" width="250" hei
 ght="68" /></p><ul class="washu-ppi-contact-list"><li class="washu-ppi-cont
 act"><strong>Brenda Chapman</strong><br />Hospital Representative</li><li c
 lass="washu-ppi-phone">314-757-0559</li><li class="washu-ppi-email"><a href
 ="mailto:brenda.chapman@astellas.com">brenda.chapman@astellas.com</a></li><
 li class="washu-ppi-website"><a href="https://www.astellas.com/">stellas.co
 m/us/</a></li></ul><hr /><p><img class="alignnone size-full wp-image-28864"
  src="https://infectiousdiseases.wustl.edu/app/uploads/2022/08/janssen.png"
  alt="" width="354" height="78" /></p><ul class="washu-ppi-contact-list"><l
 i><strong style="font-size: 1.125rem\;">Megan Wynn<br /></strong>Senior Sal
 es Representative</li><li>217-741-1622</li><li><a href="mailto:mWynn@ITS.JN
 J.com">MWynn@ITS.JNJco</a></li><li class="washu-ppi-website"><a href="https
 ://www.janssen.com/us/">janssen.com/us/</a></li></ul><p><strong>Symtuza</st
 rong></p><hr /><p><img class="alignnone size-full wp-image-19174" src="http
 s://infectiousdiseases.wustl.edu/app/uploads/2021/03/Thera-transparent.png"
  alt="" width="213" height="54" /></p><ul class="washu-ppi-contact-list"><l
 i class="washu-ppi-contact"><strong>Bryan O'Dea</strong><br />Regional Sale
 s Manager</li><li class="washu-ppi-phone">917-589-2222</li><li class="washu
 -ppi-email"><a href="mailto:Bryan.O’Dea@RSM.theratech.com ">Bryan.O’Dea@RSM
 .theratech.com</a></li><li class="washu-ppi-contact"><b>Caroline Cullum</b>
 <br />Key Account Manager</li><li class="washu-ppi-phone">901-305-5580</li>
 <li class="washu-ppi-email"><a href="mailto:ccullum@theratech.com">ccullum@
 theratech.com</a></li><li class="washu-ppi-website"><a href="https://www.th
 eratech.com/">Theratech.com</a></li></ul><p><strong>Tragarzo\, </strong><st
 rong>Egrifta SV</strong></p><hr /></div></div><p><img class="alignnone wp-i
 mage-28867" src="https://infectiousdiseases.wustl.edu/app/uploads/2022/08/F
 erring-logoCR.jpg" alt="" width="275" height="129" /></p><ul class="washu-p
 pi-contact-list"><li class="washu-ppi-contact"><strong>Andrew Greaves</stro
 ng><br />Regional Business Director</li><li class="washu-ppi-phone">314-973
 -0694</li><li class="washu-ppi-email"><b></b><a href="mailto:Andrew.Greaves
 @ferring.com">Andrew.Greaves@ferring.com</a></li></ul><ul class="washu-ppi-
 contact-list"><li class="washu-ppi-contact"><strong>Genevieve Stransky</str
 ong><br />Institutional Sales SpecialistBusiness Director</li><li class="wa
 shu-ppi-phone">636-2408452</li><li class="washu-ppi-email"><b></b><a href="
 mailto:Genevieve.Stransky@ferring.com">Genevieve.Stransky@ferring.com</a></
 li><li><a href="https://ferringusa.com/">ferringusa.com</a></li></ul><hr />
 <p><img class="alignnone wp-image-28846 size-medium" src="https://infectiou
 sdiseases.wustl.edu/app/uploads/2022/08/Merck-transp-350x112.png" alt="" wi
 dth="350" height="112" /></p><ul class="washu-ppi-contact-list"><li class="
 washu-ppi-contact"><strong>Lisa Thomas</strong><br />Virology Representativ
 e</li><li class="washu-ppi-phone">314-704-6435</li><li class="washu-ppi-ema
 il"><a href="mailto:lisa_r_thomas@merck.com">lisa_r_thomas@merck.com</a></l
 i><li class="washu-ppi-website"><a href="https://www.merck.com/">Merck.com<
 /a></li></ul><p> </p>
LOCATION:Engineers' Club of St. Louis
GEO:38.641459;-90.252669
ORGANIZER;CN="Susan Wightman":MAILTO:wightman.susan@wustl.edu
URL;VALUE=URI:https://infectiousdiseases.wustl.edu/events/event/id-society-
 of-st-louis-reception-and-meet-with-our-exhibitors-september-15-2022-just-p
 rior-to-cme-event/
END:VEVENT
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
DTSTART:20220313T080000
TZNAME:CDT
END:DAYLIGHT
END:VTIMEZONE
END:VCALENDAR